Seroprevalence of antibodies against Treponema pallidum, Toxoplasma gondii, rubella virus, hepatitis B and C virus, and HIV in pregnant women;Seroprevalencia de anticuerpos freute a Treponema pallidum, Toxoplasma gondii, virus de la rubéola, virus de la hepatitis B y C y VIH en mujeres gestantes

Enfermedades Infecciosas y Microbiologia Clinica

Volumn 22, Issue 9, 2004, Pages 512-516

  Gutiérrez Zufiaurre, Nieves ^a   Sánchez Hernández, Javier ^a   Muñoz, Santiago ^a   Marín, Raquel ^a   Delgado, Nuria ^a   Sáenz, Ma Carmen ^a,b   Muñoz Bellido, Juan Luis ^a   García Rodríguez, José Ángel ^a,b  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b HOSPITAL UNIVERSITARIO DE SALAMANCA   (Spain)

Author keywords

HBV; HCV; HIV; Pregnancy serology; Rubella; Syphilis; Toxoplasmosis

Indexed keywords

BACTERIUM ANTIBODY; HEPATITIS B ANTIBODY; HEPATITIS B SURFACE ANTIGEN; HEPATITIS C ANTIBODY; HUMAN IMMUNODEFICIENCY VIRUS ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; RUBELLA ANTIBODY; VIRUS ANTIBODY; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PROTOZOON ANTIBODY; RUBELLA ANTIBODIES;

ADULT; ANTIBODY DETECTION; ARTICLE; FEMALE; HEPATITIS B; HEPATITIS B VIRUS; HEPATITIS C; HEPATITIS C VIRUS; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IMMUNIZATION; INTRAVENOUS DRUG ABUSE; MAJOR CLINICAL STUDY; PREGNANCY; RUBELLA VIRUS; SEROPREVALENCE; SPAIN; SYPHILIS; TOXOPLASMA GONDII; TOXOPLASMOSIS; TREPONEMA PALLIDUM; BLOOD; EPIDEMIOLOGY; IMMUNOLOGY; PARITY; PREGNANCY COMPLICATION; RETROSPECTIVE STUDY; RUBELLA;

ADULT; ANTIBODIES, BACTERIAL; ANTIBODIES, PROTOZOAN; ANTIBODIES, VIRAL; FEMALE; HEPATITIS B; HEPATITIS B ANTIBODIES; HEPATITIS C; HEPATITIS C ANTIBODIES; HIV ANTIBODIES; HUMANS; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; PARITY; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; RETROSPECTIVE STUDIES; RUBELLA; SEROEPIDEMIOLOGIC STUDIES; SPAIN; SYPHILIS; TOXOPLASMOSIS;

EID: 9744285752     PISSN: 0213005X     EISSN: None     Source Type: Journal    
DOI: 10.1157/13067618     Document Type: Article

References (31)

1. Ministerio de Sanidad y Consumo. Informe sobre el control serológico de infecciones de transmisión vertical en la mujer embarazada. Madrid: Ministerio de Sanidad y Consumo, 1993.
2. Delgado Sánchez A, Bailón Muñoz E, Sánchez Pérez MR, Tara Arriola J, Sánchez Mariscal MD, Vázquez Molina R. Resultados y análisis de la investigación de HBsAg en las embarazadas de un centro de salud durante 4 años. Aten Primaria 1990;7:556-8.
3. Panizo Delgado A, Martínez de Artola V, Panizo Santos C. Seroprevalence of hepatitis B virus markers in pregnant women attending a public hospital in Navarra. Rev Clin Esp 1994;194:891-6.
4. Ranger S, Mounier M, Denis F, Alain J, Baudet J, Tabaste JL, et al. Prevalence of hepatitis B (HBsAg, HBeAg, DNA) and delta virus markers, in about 10,000 pregnant women in Limoges (France). Pathol Biol (Paris) 1990;38:694-9.
5. Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: a seroepidemiology study. Eur J Epidemiol 2000;16:87-91.
6. WHO and the Viral Hepatitis Prevention Board. Global surveillance and control of hepatitis C. J Viral Hepat 1999;6:35-47.
7. Ohto H, Terezawa S, Sasaki N, Sasaki NO, Hino K, Ishiwata C. Transmission of hepatitis C virus from mothers to infants. N Engl J Med 1994;330:744-50.
8. Sabatino G, Ramenghi LA, Dimarzio M, Pizzigallo E. Vertical transmission of hepatitis C virus. An epidemiological study of 2980 pregnant women in Italy. Eur J Epidemiol 1996;12:443-7.
9. Marcellin P, Bernau J, Martinot-Peignoux M, Larzul D, Xu LZ, Tran S, et al. Prevalence of hepatitis C virus infection in asympthomatic anti-HIV 1 negative pregnant women and their children. Dig Dis Sci 1993;38:2151-5.
10. Manzini P, Saracco G, Cerchier A, Riba C, Musso A, Riccoti E, et al. Human immunodeficiency virus infection as risk factor for mother to child hepatitis C virus transmission. Persistence of antihepatitis C virus in children associated with the mother's antihepatitis C virus immunoblotting pattern. Hepatology 1995;21:328-32.
11. Salleras L, Bruguera M, Vidal J, Plans P, Domínguez A, Navas E, et al. Seroepidemiology of hepatitis C virus infection in pregnant women in Catalonia. Med Clin (Bare) 1994;103:721-4.
12. Muñoz-Almagro C, Juncosa T, Fortuny C, Guillén JJ, González-Cuevas A, Latorre C. Prevalence of hepatitis C virus in pregnant women and vertical transmission. Med Clin (Barc) 2002;118:452-4.
13. Salmerón J, Giménez F, Torres C, Ros R, Palacios A, Quintero D, et al. Epidemiology and prevalence of seropositivity for hepatitis C virus in pregnant women in Granada. Rev Esp Enferm Dig 1998;90:841-50.
14. Sola R, Cruz de Castro E, Hombrados M, Planas R, Coll S, Jardi RS, et al. Prevalence of hepatitis B, and hepatitis C viruses in different countries of Catalonia, Spain: cross-sectional study. Med Clin (Bare) 2002;119:90-5.
15. Riestra S, Fernández E, Leiva P, García S, Ocio G, Rodrigo L. Prevalence of hepatitis C virus infection in the general population of northern Spain. Eur J Gastroenterol Hepatol 2001;13:477-81.
16. Ades AE, Parker S, Walker J, Cubitt WD, Jones R. HCV prevalence in pregnant women in the UK. Epidemiol Infect 2000;125:399-405.
17. Baldo V, Floreani A, Menegon T, Grella P, Paternoster DM, Trivello R. Hepatitis C virus, hepatitis B virus and human immunodeficiency virus infection in pregnant women in North-East Italy: a seroepidemiological study. Eur J Epidemiol 2000;16:87-91.
18. European Collaborative Study. HIV infected pregnant women and vertical transmission in Europe since 1986. AIDS 2001;15:761-70.
19. Law MG, Downs AM, Brunet JB, Kaldor JM. Time trends in HIV infection among pregnant women in Europe. AIDS 1998;12:211-6.
20. Davison CF, Holland FJ, Newell ML, Hudson CN, Peckham CS. Screening of HIV infection in pregnancy. AIDS Care 1993;5:135-40.
21. Lindsay MK. A protocol for routine voluntary antepartum HIV antibody screening. Am J Obstet Gynecol 1993;168:476-9.
22. Mofenson L. Epidemiology and determinants of vertical HIV transmission. Semin Pediatr Infect Dis 1994;5:252-65.
23. Connor E, Sperling R, Gelber R, Kiselev P, Scott G, O'Sullivan MJ, et al. Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. N Engl J Med 1994;331:1173-80.
24. Rogres MF, Jaffe HW. Reducing the risk of maternal-infant transmission of HIV: a door is opened. N Engl J Med 1994;331:1222-3.
25. Bryson Y. Perinatal transmission: associated factors and therapeutic approaches. XI International Conference on AIDS. Vancouver, 1996.
26. Iribarren JA, Ramos JT, Guerra L, Coll O, De José MI, Domingo P, et al. Prevencion de la transmisión vertical y tratamiento de la infección por el virus de la inmunodeficiencia humana en la mujer embarazada. Enferm Infecc Microbiol Clin 2001;19:314-35.
27. Liesenfeld O, Montoya JG, Kinney S, Press C, Remington JS. Effect of testing for IgG avidity in the diagnosis of Toxoplasma gondii infection in pregnant women: experience in a US reference laboratory. J Infect Dis 2001;15;183:1248-53.
28. Rodríguez JC, Alcantara MJ, Royo G. Toxoplasmosis in pregnancy: new diagnostic techniques. Enferm Infecc Microbiol Clin 1996;14:145-9.
29. Jaqueti J, Hernández-García R, Nicolás D, Martínez-Hernández D, Navarro-Gallar F, García- Estebán RJ. Serology against Toxoplasma gondii in pregnant women. Development of prevalence rates in the course of 4 years. Rev Clin Esp 1991;188:278-80.
30. Guerra García C, Fernández Sanpedro J. Seroprevalence of Toxoplasma gondii in pregnant women. Aten Primaria 1995;16:151-3.
31. Gutiérrez J, Roldán C, Maroto MC. Seroprevalence of human toxoplasmosis. Microbios 1996;85:73-5.